In the present paper, several points regarding Helicobacter pylori treatment are reviewed,
with the following conclusions:(1) all different proton pump inhibitors (PPIs) are equivalent …

В монографии обобщены данные современной литературы и результаты
исследований автора, посвященные ингибиторам протонного насоса. Основное …

Gastroduodenal disease associated with Helicobacter pylori infection are reviewed as well
as the diagnostic approach. Generally, there are by and large two ways in which a diagnosis …

Aim. The combination of a proton pump inhibitor (PPI) or ranitidine‐bismuth‐citrate (Rbc)
and two antibiotics for 7–10 days are, at present, the preferred treatments in Helicobacter …

Helicobacter pylori infection, which is present in 30-60% of the population in developed
countries and in more than 60% in developing countries, is established to be a major cause …

Helicobacter pylori (Hp) is a Gram-negative bacteria able to live in the human stomach, a
very surprising fact considering the acid environment of gastric mucosa. Identified by …

Background: The effect of knowledge of Helicobacter pylori eradication rates on physician
choice of treatment regimen is unknown. As practice variation results in differences in …

Ziel dieser Übersicht ist es, ökonomische Aspekte der H.-pylori-Infektion zu analysieren. Die
Beseitigung der Infektion ist für die Ulkuserkrankung mit einem gesicherten ökonomischen …

Dyspepsie ist ein auf den Oberbauch projizierter Beschwerdekomplex, dem
unterschiedliche organische Erkrankungen oder funktionelle Störungen des oberen …